Aethlon Medical says shareholders reject proposal to authorize 20,000,000 preferred shares

• Aethlon Medical filed an amended 8-K to correct its prior disclosure on a shareholder vote at the 2026 annual meeting.
• Proposal to authorize 20,000,000 shares of preferred stock failed to pass, reversing the earlier statement that it was adopted.
• Only 204,122 shares voted for the measure, below the 355,569 votes required from a majority of outstanding common shares.
• The company’s charter was not amended to add preferred stock authorization.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aethlon Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-007613), on October 05, 2026, and is solely responsible for the information contained therein.